Cleared Traditional

K203227 - Elecsys HCG STAT

K203227 is an FDA 510(k) clearance for Elecsys HCG STAT, manufactured by Roche Diagnostics. The device is a Class 2 Chemistry device with product code DHA cleared through the Traditional 510(k) pathway after a 289-day FDA review.

K203227 · Roche Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2021
Decision
289d
Days
Class 2
Risk

K203227 is an FDA 510(k) clearance for the Elecsys HCG STAT. Classified as System, Test, Human Chorionic Gonadotropin (product code DHA), Class II - Special Controls.

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on August 18, 2021 after a review of 289 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Roche Diagnostics devices

FDA 510(k) Submission Details - K203227

510(k) Number K203227 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 2020
Decision Date August 18, 2021
Days to Decision 289 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
201d slower than avg
Panel avg: 88d · This submission: 289d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHA Device Classification - Class 2, Special Controls

Product Code DHA System, Test, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DHA System, Test, Human Chorionic Gonadotropin

All 54
Devices cleared under the same product code (DHA) and FDA review panel - the closest regulatory comparables to K203227.
Alinity i Total B-hCG Reagent Kit, Alinity c Glucose Reagent Kit, Alinity c ICT Sample Diluent, Alinity ci-series
K230790 · Abbott Laboratories · May 2023
Access Total ßhCG (5th IS)
K221990 · Beckman Coulter, Inc. · Dec 2022
Diazyme DZ-Lite iFlash Total beta-hCG Assay, Diazyme DZ-Lite iFlash 1800 Chemiluminescence Immunoassay Analyzer
K212221 · Diazyme Laboratories, Inc. · Dec 2021
ADVIA Centaur® Total hCG assay
K200210 · Siemens Healthcare Diagnostics, Inc. · Jul 2021
MAGLUMI 2000 HCG/ß-HCG
K192547 · Shenzhen New Industries Biomedical Engineering Co., Ltd. · Jan 2020
Atellica IM Total hCG (ThCG)
K192790 · Siemens Healthcare Diagnostics, Inc. · Oct 2019